Pilot Study Evaluating the Impact of Stress Reduction on Atherosclerotic : Heart and Mind Study
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-65
SponsorMassachusetts General Hospital
About this trial
The plot study aims to evaluate the effect of 8 weeks of stress reducing intervention on atherosclerotic plaque inflammation in adults, as quantified by positron emission tomography (PET) with fluorine-2-deoxy-D-glucose (FDG) in individuals with increased psychosocial stress.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
• Aged between 30-65 years
Identifies as having increased levels of stress and/or has a Perceived Stress Scale (PSS) score >5 at baseline, and is interested in participating
Disqualifiers
Perceived Stress Scale (PSS) score <6
Trial design
Design model
Parallel
Treatments tested in this trial
Stress Reduction
BehavioralThe stress reduction program is a multimodal mind-body resiliency program that incorporates 3 core components into each session: * Elicitation of the Relaxation Response (RR) through mind-body techniques; * Discussion about stress awareness to learn how to identify personal stressors and experiences of stress; and * Coping strategies and adaptive perspective-taking to promote positive well-being.
Treatment groups
30 Participants
are divided into 2 treatment groupsGroup A: Stress ReductionExperimental treatment 1 intervention
Group B: ControlNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Change in arterial inflammation by PET
Change in arterial inflammation based on FDG PET - from initial imaging to repeat imaging.
Time frame
2 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov